Eva Giménez, founder of Asdent and mother of Nacho, the first Spanish child with Dent's disease, will run the next edition of the Titan Desert. She will be accompanied by the Stern Motor-Asdent team which, made up of 7 members, will pedal 600 km through the desert for 6 days in what has already been named the toughest edition of all. The Stern Motor dealer network (Movento group), aware of the importance of Eva's sporting and solidarity challenge, will provide financial support to the entire team before and during the desert race.Five years after crossing the finish line of the Titan Desert, Eva Giménez returns to embark on this adventure for her son. She does it accompanied by a team of cycling fans, all members of Asdent, running for a cause: get money for Dent, considered a rare disease, which continues to be investigated at the Vall d'Hebrón Research Institute (VHIR) to obtain a medication that could stop it.At VHIR, Dr. Gema Ariceta, head of the Paediatric Nephrology Service at Vall d'Hebron Hospital, and Dr. Anna Meseguer, head of the http://en.vhir.org/portal1/grup-equip.asp?s=recerca&contentid=186829 Renal Physiopathology group at CIBBIM Nanomedic, are leading the research onDent disease. Her project aims to discover new genes and relevant mechanisms that explain the progression of the disease, beyond the gene mutation itself. Only two genes are known to be involved, CLC5 and ORCL, which cause kidney and eye changes in some cases. But in addition, there is an important percentage of patients who suffer from the disease without affectation in any of these genes.For Eva, with reduced mobility and a disability of 45% due to multiple sclerosis, participating in the Titan Desert is a titanic effort. "To raise funds, very visible actions were needed, to do the unimaginable, and the Titan Desert was precisely what we needed to give visibility to my son's disease," she explains and, with respect to the 2018 edition, adds that "I would do it as many times as necessary, the biggest challenge of my life is to get a cure for Nacho."